These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19549264)

  • 21. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
    Baert F; Moortgat L; Van Assche G; Caenepeel P; Vergauwe P; De Vos M; Stokkers P; Hommes D; Rutgeerts P; Vermeire S; D'Haens G; ;
    Gastroenterology; 2010 Feb; 138(2):463-8; quiz e10-1. PubMed ID: 19818785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease.
    Reinisch W; Panés J; Lémann M; Schreiber S; Feagan B; Schmidt S; Sturniolo GC; Mikhailova T; Alexeeva O; Sanna L; Haas T; Korom S; Mayer H
    Am J Gastroenterol; 2008 Sep; 103(9):2284-92. PubMed ID: 18671816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
    Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
    Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological and clinical features of Spanish patients with Crohn's disease. Spanish Epidemiological and Economic Study Group on Crohn's disease.
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1121-7. PubMed ID: 10524641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
    Vermeire S; van Assche G; Rutgeerts P
    Aliment Pharmacol Ther; 2007 Jan; 25(1):3-12. PubMed ID: 17229216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Events at the host-microbial interface of the gastrointestinal tract. V. Paneth cell alpha-defensins in intestinal host defense.
    Bevins CL
    Am J Physiol Gastrointest Liver Physiol; 2005 Aug; 289(2):G173-6. PubMed ID: 16014978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Azathioprine or ileocolic resection for steroid-dependent terminal ileal Crohn's disease? A Markov analysis.
    Kennedy ED; Urbach DR; Krahn MD; Steinhart AH; Cohen Z; McLeod RS
    Dis Colon Rectum; 2004 Dec; 47(12):2120-30. PubMed ID: 15657664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profile of soluble cytokine receptors in Crohn's disease.
    Gustot T; Lemmers A; Louis E; Nicaise C; Quertinmont E; Belaiche J; Roland S; Van Gossum A; Devière J; Franchimont D
    Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and regulation of antimicrobial peptides in the gastrointestinal tract.
    Cunliffe RN; Mahida YR
    J Leukoc Biol; 2004 Jan; 75(1):49-58. PubMed ID: 14525966
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crohn's disease-derived monocytes fail to induce Paneth cell defensins.
    Courth LF; Ostaff MJ; Mailänder-Sánchez D; Malek NP; Stange EF; Wehkamp J
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):14000-5. PubMed ID: 26512113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crohn's disease--defect in innate defence.
    Gersemann M; Wehkamp J; Fellermann K; Stange EF
    World J Gastroenterol; 2008 Sep; 14(36):5499-503. PubMed ID: 18810765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of human beta defensin 2 in thermal injury.
    Milner SM; Bhat S; Buja M; Gulati S; Poindexter BJ; Bick RJ
    Burns; 2004 Nov; 30(7):649-54. PubMed ID: 15475136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Over-expression of paneth cell-derived anti-microbial peptides in the gut of patients with ankylosing spondylitis and subclinical intestinal inflammation.
    Ciccia F; Bombardieri M; Rizzo A; Principato A; Giardina AR; Raiata F; Peralta S; Ferrante A; Drago S; Cottone M; Pitzalis C; Triolo G
    Rheumatology (Oxford); 2010 Nov; 49(11):2076-83. PubMed ID: 20688803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced Paneth cell alpha-defensins in ileal Crohn's disease.
    Wehkamp J; Salzman NH; Porter E; Nuding S; Weichenthal M; Petras RE; Shen B; Schaeffeler E; Schwab M; Linzmeier R; Feathers RW; Chu H; Lima H; Fellermann K; Ganz T; Stange EF; Bevins CL
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18129-34. PubMed ID: 16330776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Variations at rs3129891 and rs77005575 are Associated With Reduced Expression of Enteric α-defensins in IBD Patients.
    Deng Q; Tan G; Deng F; Zhi F
    J Clin Gastroenterol; 2020 Jul; 54(6):e50-e55. PubMed ID: 31403980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4.
    Wehkamp J; Wang G; Kübler I; Nuding S; Gregorieff A; Schnabel A; Kays RJ; Fellermann K; Burk O; Schwab M; Clevers H; Bevins CL; Stange EF
    J Immunol; 2007 Sep; 179(5):3109-18. PubMed ID: 17709525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of human alpha- and beta-defensins mRNA in gastrointestinal epithelia.
    Frye M; Bargon J; Lembcke B; Wagner TO; Gropp R
    Eur J Clin Invest; 2000 Aug; 30(8):695-701. PubMed ID: 10964161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective paneth cell-mediated host defense in pediatric ileal Crohn's disease.
    Perminow G; Beisner J; Koslowski M; Lyckander LG; Stange E; Vatn MH; Wehkamp J
    Am J Gastroenterol; 2010 Feb; 105(2):452-9. PubMed ID: 19904243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defensins couple dysbiosis to primary immunodeficiency in Crohn's disease.
    Chamaillard M; Dessein R
    World J Gastroenterol; 2011 Feb; 17(5):567-71. PubMed ID: 21350705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.